Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial
在2019冠状病毒病肺炎患者中,在标准治疗基础上加用三天伊卡替班:一项随机、开放标签、II期概念验证试验
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciac984
Malchair, Pierre; Giol, Jordi; García, Vanesa; Rodríguez, Orlando; Ruibal, José Carlos; Zarauza, Alvaro; Llopis, Ferrán; Matellán, Leire; Bernal, Tania; Solís, Beatriz; Otero, Aurema; Carnaval, Thiago; Jofre, Hector; Jacob, Javier; Solanich, Xavier; Antolí, Arnau; Rocamora, Gemma; Videla, Sebastián